GPP
Great Point Partners’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.26M | Sell |
200,000
-45,272
| -18% | -$1.42M | 4.07% | 10 |
|
|
2025
Q1 | $8.23M | Hold |
245,272
| – | – | 4.36% | 8 |
|
|
2024
Q4 | $9.61M | Buy |
+245,272
| New | +$9.61M | 4.53% | 10 |
|
|
2024
Q2 | – | Sell |
-456,148
| Closed | -$19.6M | – | 40 |
|
|
2024
Q1 | $19.6M | Sell |
456,148
-143,852
| -24% | -$6.19M | 3.06% | 14 |
|
|
2023
Q4 | $27.6M | Buy |
600,000
+99,999
| +20% | +$4.61M | 4.71% | 6 |
|
|
2023
Q3 | $17.1M | Sell |
500,001
-29,999
| -6% | -$1.02M | 3.11% | 13 |
|
|
2023
Q2 | $20.4M | Sell |
530,000
-288,505
| -35% | -$11.1M | 3.99% | 9 |
|
|
2023
Q1 | $29.3M | Sell |
818,505
-31,495
| -4% | -$1.13M | 5.75% | 2 |
|
|
2022
Q4 | $33.5M | Hold |
850,000
| – | – | 6.57% | 2 |
|
|
2022
Q3 | $30.7M | Sell |
850,000
-254,334
| -23% | -$9.18M | 7.39% | 1 |
|
|
2022
Q2 | $33.6M | Buy |
1,104,334
+184,334
| +20% | +$5.61M | 8.06% | 1 |
|
|
2022
Q1 | $28.1M | Sell |
920,000
-30,000
| -3% | -$917K | 6.8% | 2 |
|
|
2021
Q4 | $29.7M | Buy |
950,000
+250,000
| +36% | +$7.81M | 6.59% | 3 |
|
|
2021
Q3 | $10.7M | Buy |
+700,000
| New | +$10.7M | 2.49% | 17 |
|